Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03462940 · ClinicalTrials.gov registry record · NA
Effects of TUDCA on Endothelial Function in Type 2 DM
A NA study, sponsored by Boston University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03462940: Clinical Trial NA study, sponsored by Boston University.
NCT03462940 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03462940, a NA study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The pilot study is designed to investigate the acute and chronic effects of the diet supplement tauroursodeoxycholic acid (TUDCA) on endothelial function in participants with type 2 diabetes mellitus.
Primary Outcome
Endothelium -dependent flow-mediated dilation of the brachial artery by ultrasound and fingertip tonometry at baseline and 5-minute cuff occlusion of the upper arm.
Interventions
- DIETARY_SUPPLEMENT Tauroursodeoxycholic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2021-02-09 |
| Phase | NA |
Why NCT03462940 stopped before completion
NCT03462940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Tauroursodeoxycholic acid is the first listed.
NCT03462940 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03462940 about?
NCT03462940 is a clinical study titled "Effects of TUDCA on Endothelial Function in Type 2 DM". The pilot study is designed to investigate the acute and chronic effects of the diet supplement tauroursodeoxycholic acid (TUDCA) on endothelial function in participants with type 2 diabetes mellitus.
What is the current status of trial NCT03462940?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-04-02. Estimated completion is 2021-02-09.
What interventions are being tested in trial NCT03462940?
The interventions under investigation include: Tauroursodeoxycholic acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03462940?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03462940's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI